![Mark Rothera](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Rothera
Vorstandsvorsitzender bei
VIRACTA THERAPEUTICS, INC.
Profil
Mark A. Rothera is currently Chief Executive Officer at Viracta Therapeutics, Inc., Chief Executive Officer & Director at TreeFrog Therapeutics SAS starting in 2025, Director at Genpharm Services, and President & Director at Orchard Therapeutics North America.
Former roles include President, CEO & Executive Director at Silence Therapeutics Plc from 2020 to 2022; President, Chief Executive Officer & Director at Orchard Therapeutics (Europe) Ltd. from 2017 to 2020; President, CEO & Executive Director at Orchard Therapeutics Plc from 2018 to 2020; Director at Alliance for Regenerative Medicine; Director at INVO Fertility, Inc.; Chief Commercial Officer at PTC Therapeutics, Inc. from 2013 to 2017; Executive VP-Strategy & Business Development at Aegerion Pharmaceuticals, Inc. from 2012 to 2013; President & General Manager-Commercial Operations at Shire Human Genetic Therapies, Inc. from 2006 to 2012; and Vice President-Europe, Middle East & Africa at CHIRON Biopharmaceuticals from 2000 to 2005.
Education includes graduate studies at the University of Cambridge and an MBA from INSEAD.
Aktive Positionen von Mark Rothera
| Unternehmen | Position | Beginn |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Vorstandsvorsitzender | - |
Genpharm Services
 Genpharm Services Advertising/Marketing ServicesCommercial Services Provides pharmaceutical marketing and consulting services | Direktor/Vorstandsmitglied | - |
Orchard Therapeutics North America
 Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services | Präsident | - |
TreeFrog Therapeutics SAS
 TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Operates as a stem cell company | Vorstandsvorsitzender | 15.12.2025 |
Ehemalige bekannte Positionen von Mark Rothera
| Unternehmen | Position | Ende |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Vorstandsvorsitzender | 21.02.2022 |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Vorstandsvorsitzender | 17.03.2020 |
| ORCHARD THERAPEUTICS PLC | Vorstandsvorsitzender | 17.03.2020 |
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 09.08.2017 |
| AEGERION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2013 |
Ausbildung von Mark Rothera
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Health Technology |
CHIRON Biopharmaceuticals | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Genpharm Services
Genpharm Services Advertising/Marketing ServicesCommercial Services Provides pharmaceutical marketing and consulting services | Commercial Services |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
TreeFrog Therapeutics SAS
TreeFrog Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Operates as a stem cell company | Commercial Services |
Orchard Therapeutics North America
Orchard Therapeutics North America BiotechnologyHealth Technology Provides biotechnology research services | Health Technology |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
